A Therapeutic Intelligence company.

Building biology that wasn't there.

EPIX starts from the function a medicine needs to perform and designs the protein that performs it — de novo molecular recognition, engineered against the complex targets conventional antibodies can't reach, with the selectivity and safety margin the application demands.